Markedly prolonged disease course, with breakthrough seizures, in a glioma with an isolated IDH1 mutation.
Neurooncol Adv
; 4(1): vdac004, 2022.
Article
in En
| MEDLINE
| ID: mdl-35128400
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Neurooncol Adv
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom